Exec Edge hosted a fireside chat at the 2024 ICR Conference with Barry McGowan, CEO of Fogo de Chao. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed its new locations in Los Angeles, the importance of brand building and...

Exec Edge hosted a fireside chat at the  2024 ICR Conference with Christine Schindler, Co-Founder & CEO of PathSpot – AK. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed its flagship HandScanner solution and the launch of...

Exec Edge hosted a fireside chat at the 2024 ICR Conference with Bob Wright, President and CEO of Potbelly Corp. (NASDAQ: PBPB). The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the company’s latest franchise agreements and its...

  Exec Edge hosted a fireside chat at the 2024 ICR Conference with Kevin Duffy, CEO of iFIT. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the company’s latest brand campaigns and how they contribute to expand...

By Karen E. Roman Tock, a Squarespace, Inc. company (NYSE: SQSP), said its new service can help restaurants drive profitability while offering unique experiences to diners. Multi-Experience Tables allow restaurants to offer customers distinctive experiences at the same table, the company...

Exec Edge hosted a fireside chat at the 2024 ICR Conference with Executive Chairman Mark Goldston and Co-Founder & CEO Carl Daikeler of The Beachbody Co., Inc. or BODi (NYSE: BODY). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed...

  By Karen E. Roman DecisionRx, Inc., a value-based healthcare company focused on minimizing healthcare costs by addressing medication failure, announced a $100 million credit facility from global investment firm Carlyle. Carlyle also obtained an option to acquire 25% of...

  By Healthcare Edge Editorial Staff DecisionRx, Inc., a value-based healthcare company focused on minimizing healthcare costs by addressing medication failure, announced a $100 million credit facility from global investment firm Carlyle. Carlyle also obtained an option to acquire 25%...

By Exec Edge Editorial Staff Apollomics Inc. (Nasdaq: APLM) said it completed patient enrollment in its Phase 3 bridging study for uproleselan in Chinese patients with relapsed or refractory acute myeloid leukemia. The study, conducted across 20 sites in Greater...

By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanjeev Luther as incoming President and Chief Executive Officer from Jan. 1, 2024. Mr. Luther emphasized his commitment to advancing the reach and promise of mRNA cell...